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Abstract
Background: Mycobacterium tuberculosis phoP mutant SO2 derived from a clinical isolate was shown to be attenuated in
mouse bone marrow-derived macrophages and in vivo mouse infection model and has demonstrated a high potential as
attenuated vaccine candidate against tuberculosis.
Methodology/Principal Findings: In this study, we analyze the adhesion and the intracellular growth and trafficking of SO2
in human macrophages. Our results indicate an enhanced adhesion to phagocitic cells and impaired intracellular replication
of SO2 in both monocyte-derived macrophages and human cell line THP-1 in comparison with the wild type strain,
consistent with murine model. Intracellular trafficking analysis in human THP-1 cells suggest that attenuation of SO2 within
macrophages could be due to an impaired ability to block phagosome-lysosome fusion compared with the parental M.
tuberculosis strain. No differences were found between SO2 and the wild-type strains in the release and mycobacterial
susceptibility to nitric oxide (NO) produced by infected macrophages.
Conclusions/Significance: SO2 has enhanced ability to bind human macrophages and differs in intracellular trafficking as to
wild-type M. tuberculosis. The altered lipid profile expression of the phoP mutant SO2 and its inability to secrete ESAT-6 is
discussed.
Citation: Ferrer NL, Gomez AB, Neyrolles O, Gicquel B, Martin C (2010) Interactions of Attenuated Mycobacterium tuberculosis phoP Mutant with Human
Macrophages. PLoS ONE 5(9): e12978. doi:10.1371/journal.pone.0012978
Editor: Anil Kumar Tyagi, University of Delhi, India
Received July 9, 2010; Accepted August 31, 2010; Published September 24, 2010
Copyright:  2010 Ferrer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Spanish Ministerio de Educacion y Ciencia (BES-2003-1088), Ministerio de Ciencia e Innovacion (BIO2005-07949-C02-01,
BIO2008-01561) and by the European TBVAC FP6-503367 and NEWTBVAC FP7 241745 Projects. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: carlos@unizar.es
¤a Current address: Departamento de Microbiologı ´a II, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain
¤b Current address: Mycobacterial Interactions with Host Cells, IPBS, CNRS, Toulouse, France
Introduction
Tuberculosis (TB) is a leading cause of mortality by infectious
disease throughout the world [1], along with AIDS and malaria
[2,3]. It is estimated that the bacilli of tuberculosis infect
approximately one-third of the world’s population causing two
million deaths each year [4]. The HIV/AIDS pandemic, the
deterioration of public health infrastructures in developing
countries, and the emergence of multidrug-resistant (MDR-TB)
and even extensively drug resistant (XDR) forms of Mycobacterim
tuberculosis (Mtb) have further contributed to spread and transmis-
sion of the disease [5].
Currently, the Mycobacterium bovis bacille Calmette–Gue ´rin
(BCG) strain is the only vaccine available for the prevention of
TB in humans. This live- attenuated vaccine, originally derived by
serial passages of a virulent strain of M. bovis, has been used to
prevent TB since 1921. Although BCG protects against severe
forms of childhood TB, this vaccine is ineffective in preventing
adult pulmonary TB, which is the major form of the disease in
endemic areas [2,3,6]. Recently, the genome sequences of the Mtb
clinical isolate H37Rv and of the BCG substrain 1173 Pasteur,
which are widely used as reference strains in many mycobacterial
genetics laboratories, have been published [7]. In this context, and
with the relatively poor efficacy of BCG in a number of clinical
trials [6], major efforts are being undertaken worldwide to develop
more effective vaccines against pulmonary TB. A combination of
drug treatment regimens with efficacious prophylactic vaccines
could therefore potentially go a long way to reduce incidence of
the disease in TB endemic areas.
The aims of the ‘classical’ live vaccine strategy are to generate
host immune responses that mimic natural infection, but without
causing disease [8]. The development of rationally attenuated
mutants of Mtb offers the prospect of novel potential vaccine
candidates against TB. By inactivating key genes involved in
virulence, it allows for the possibility of using a live-attenuated
vaccine that is safe and can induce the appropriate protective
immune responses without generating the pathology associated
with progression of disease resulting in improved protective
efficacy. An advantage of the Mtb live-attenuated vaccine strategy
is that many immunologically important genes are conserved in
the genome, unlike M. bovis BCG substrains where these are
deleted [9].
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are important elements in the adaptive response of prokaryotes to
a variety of environmental stimuli [10] and are also implicated in
virulence regulation [11]. PhoP/R has been described in Mtb as a
two-component regulatory system and has been shown to play an
essential role in Mtb virulence [12]. In previous work, our
laboratory constructed a phoP mutant from a clinical isolate of Mtb
by introducing a marked disruption in the phoP gene, generating
the SO2 strain which exhibited impaired multiplication in vitro in
mouse bone marrow-derived macrophages, and in vivo in a mouse
infection model [12].
After in vitro murine studies, SO2 was shown to be more
attenuated than BCG in severe combined immunodeficiency
(SCID) mice and to confer equivalent immunity against pulmo-
nary TB in mice and better protection in guinea pigs when
compared with BCG [13,14]. Furthermore, recent protective
efficacy studies in rhesus macaques demonstrated that SO2
vaccination significantly reduced pathology upon intratracheal
Mtb infectious challenge, and provided significant protective effect
by reduction in C-reactive protein levels, and body weight loss and
decrease of several markers of inflammatory infection [15].
In addition to these studies, molecular assays have been
performed, showing that phoP is involved in the regulation of
complex mycobacterial cell-wall lipids implicated in the virulence
of Mtb [16–18]. Likewise, it has been demonstrated that avirulent
H37Ra strain contains a single mutation in phoP that accounts for
the absence of complex lipids [19] and impaired ESAT-6 secretion
[20] contributing to the avirulence of this strain [21].
Herein, as mycobacterial virulence is related to the initial
capacity of the microorganism to survive and grow in macro-
phages, we study the early infection of the vaccine candidate SO2
in vitro in human macrophages including peripheral blood-derived
macrophages (PBMC) as primary macrophages and the THP-1
cell line, which exhibits alveolar macrophage features when
stimulated with PMA, in comparison with its virulent wild-type
MT103 clinical strain. We compare this model with the results
observed in murine macrophages in which SO2 intracellular
replication is impaired. Moreover, we studied the first interaction
of SO2 strain with macrophages through adhesion assays and
investigated a) the trafficking involved in the internalization of
mycobacteria in THP-1 cells by immunofluorescence assays to see
possible differences in the phagosome-lysosome fusion and b) the
produced nitric oxide (NO) by infected THP-1 macrophages, as
well as the mycobacterial susceptibility to it.
Materials and Methods
Bacterial strains and growth conditions
M. bovis BCG Pasteur 1173P2, Mtb clinical isolate MT103, the
MT103 phoP mutant SO2 (kanamycin resistant), and its comple-
mented strain (kanamycin and hygromycin resistant), SO2-pSO5
[12], were used in this study. Mycobacteria were grown at 37uCi n
liquid Middlebrook 7H9 medium supplemented with 0.05%
Tween 80 and 10% Middlebrook albumin dextrose catalase
enrichment (ADC), and when required, the medium was
supplemented with 20 mg/ml of kanamycin or hygromycin. Before
use, fresh mycobacterial cultures were centrifuged at 20 g for
5 min to remove bacterial clumps.
Eukaryotic cells
Peripheral blood mononuclear cells (PBMC) from healthy
subjects from Banco de Sangre Hospital Clı ´nico Universitario
Lozano Blesa University of Zaragoza, according to institutional
guidelines, were isolated by density sedimentation over Ficoll-
Paque PLUS (Amersham Biosciences) and to isolate monocytes,
CD14+ cells were separated from total PBMCs by rosette
formation with goat erythrocytes to eliminate T lymphocytes
[22] and by negative selection with magnetic particles (Dynabeads
CD2 (Pan T) and CD19 (Pan B), DynalBiotech) as supplier’s
instructions to condense CD14+ cells, as determined by flow
cytometry with the anti-CD14 antibody. Finally, monocytes were
plated in a 24-well plate at a density of 6610
5 cells/ml in a
complete RPMI-1640 medium containing 1% penicillin-strepto-
mycin, and incubated for 7 days with medium containing 1 ml/ml
of M-CSF (macrophage-colony stimulating factor, R&D Systems).
The human monocytic cell line THP-1 was obtained from the
ECACC collection (ECACC No. 88081201) and were cultured at
37uC in a 5% CO2 atmosphere. THP-1 were maintained in
RPMI-1640 medium (GIBCO), containing 2 mM L-glutamine
and 10% fetal bovine serum. For subsequent experiments, THP-1
cell suspensions were adjusted to a concentration of 5610
5 cells/
ml in warm RPMI supplemented, seeded in 24-well plates adding
1 ml of suspension per well, and cells were allowed to adhere and
differentiate in the presence of 10 ng/ml PMA (Sigma), at 37uCi n
5% CO2 for 48 hours.
Macrophage infection with M. tuberculosis
For infection, the medium of differentiated THP-1 and blood
monocytes-derived macrophages was removed and replaced with
1 ml of bacterial suspension from each strain (Mtb MT103, its
phoP mutant SO2, and its complemented strain SO2-pSO5) in
RPMI containing 10
5 cfu/ml, to obtain a multiplicity of infection
(MOI) of 1:10, bacteria per macrophage. After 4 h at 37uC, the
medium was removed and the wells were washed three times with
RPMI to remove extracellular bacteria (reduction to a non
significant number of extracellular bacilli), before adding 1 ml of
fresh culture medium per well. On days 0 (4 h), 1, 3, 5 and 7, cells
were lysed with 500 ml of sterile water with 0.1% triton X-100, and
the number of viable intracellular bacteria was counted by plating
serial dilutions of the lysis solution onto Middlebrook 7H10 agar
supplemented with 10% OADC (oleic albumin dextrose catalase
enrichment). This infection experiment was carried out in
triplicate.
Binding of mycobacteria to THP-1
The medium overlying the THP-1 monolayer was replaced with
1 ml of ice-cold tissue culture medium. Mycobacteria were added
to the monolayer at MOI of 1:1 because of the low percentage of
adherent bacteria. The mycobacteria were allowed to adhere for
4 hours at 4uC, and after the incubation period each well was
rinsed 3 times with 1 ml of ice-cold Phosphate Buffered Salt
Solution (PBS), pH 7.4. Monolayers were subsequently treated
with 0.5 ml of Triton X-100 (Sigma) in sterile water for 10 min.
Non-specific adherence to the plastic did not occur at 4uC (data
not shown). Adherent bacteria were quantified by plating for
colony forming units (CFU) onto Middlebrook 7H10 agar.
Intracellular trafficking within THP-1
Macrophages were seeded on glass coverslips and infected
under the same conditions as the survival experiments, at MOI of
1:1. We used heat-inactivated MT103 as negative control, by
heating bacteria at 80uC for 40 min. After 48 h of infection,
coverslips were fixed with 4% paraformaldehyde (PFA) in PBS at
room temperature for 30 min. Finally, PFA was removed and cells
were maintained in PBS at 4uC until their labeling. For
LysoTracker labelling, cells were incubated at 37uC with 50 nM
of LysoTracker (Molecular Probes) during 2 h, and subsequently
washed, before fixing. Then, coverslips were permeabilized and
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PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12978incubated with a blocking solution of PBS, containing 2% FBS,
0.1% bovine serum albumin (BSA) and 1% saponin, for 30 min
and incubated with primary antibodies against LAMP-1 (late
phagosome-endosome marker), CD63 (phagolysosomal marker),
and anti-BCG for 1 h. As primary antibodies we used monoclonal
mouse anti-human LAMP-1 (Fitzgerald) diluted 1:100, monoclo-
nal mouse anti-human CD63 (Fitzgerald) diluted 1:100 and
polyclonal rabbit anti-BCG diluted 1:50 kindly provided by Dr.
Natalie Winter (Pasteur Institute, Paris, France). After the primary
labeling, cells were washed three times with PBS-1% saponin, and
incubated with fluorescent secondary antibodies in absence of light
for 1 h. As secondary antibodies: Alexa Fluor 488 F(ab’)2 fragment
of goat anti-rabbit IgG (Molecular Probes) and Alexa Fluor 594
F(ab’)2 fragment of goat anti-mouse IgG (Molecular Probes), both
of them diluted 1:100. Finally, cells were washed three times with
PBS, coverslips were mounted in Fluoromount-G (Southern
Biotech) on a microscope slide, and let at 4uC overnight. Indirect
immunofluorescence was examined using a fluorescence micro-
scope and a confocal laser-scanning microscope. To calculate the
percentage of colocalization for each coverslip, the superposition
of fluorescences for a minimum of 100 internalized isolated
bacteria (to avoid false positives) were analyzed. These assays were
performed at least two times and results were the average and
standard deviation obtained from three parallel independent
infections.
Measurement of NO production by infected THP-1 cells
Supernatants were harvested after 24, 48, 72 and 96 h from
cultures of PMA-treated THP-1 infected at MOI of 1:10, 1:1 and
10:1. The production of NO was measured indirectly by assaying
for the presence of nitrite (NO2
2) using the Griess reagent. Griess
reagent was added 1:1 with supernatants. Units of NO2
2 were
quantified from a standard curve using dilutions of NaNO2
(100 nM-100 mM) as a source of nitrite, and data were normalized
to NO production in non-infected THP-1 cells. After 15 min at
room temperature A540 values were read on a spectrophotometer.
Determination of mycobacterial susceptibility to
exogenous NO
The 7H9-ADC broth was acidified to pH 5.5, with the addition
of 2 N HCl, and filter sterilized. After that, approximately 5610
3
viable bacilli were added to tubes in 1-ml aliquots of this broth.
Then, sodium nitrite was added from a sterile 1 M stock to final
concentrations ranging between 0.5 mM and 10 nM. Sodium
nitrite was not added to control cultures. The cultures were
incubated at 37uC for 24–120 h (days 1–5), and serial dilutions
were plated onto Middlebrook 7H10-OADC agar at the indicated
days after infection and counted as described above. The obtained
CFUs from the control cultures were considered as 100% viability.
Statistical analyses
The statistical differences between strains were analyzed by the
Student’s t test. The levels of significance between strains were set
at a P value of ,0.05. Unless otherwise stated, all experiments
were performed at least three times, and the data are given as
mean values 6 SD.
Results
Impaired replication of SO2 in human macrophages
To study the intracellular replication of SO2 strain inside
human macrophages, primary cells derived from PBMC and the
human cell line THP-1 were infected at a MOI 1:10 with wild-
type MT103 or its attenuated phoP-based mutant SO2 and
mycobacterial viability was studied. In both human PBMC and
THP-1 derived macrophages, there was an impaired intracellular
growth of SO2 when compared to MT103. At day 7 of infection of
PBMC cells, MT103 had 110-fold growth increase CFU numbers,
while SO2 had a lower increase of 6-fold with respect to CFU
counts on day 0, indicating that SO2 replication was impaired
intracellularly (about 18-fold less CFU numbers) when compared
to wild-type MT103 strain (Figure 1A). The phoP-complemented
strain SO2-pSO5 largely restored the wild type growth pattern in
PBMC. Similar results were obtained in THP-1 cells, although
with a smaller degree of mycobacterial growth for all strains. In
this case, the numbers of intracellular MT103 bacilli increased 38-
fold over the 7 days of infection (Figure 1B), whereas SO2 was
characterized by a 2-fold increase in CFU as to day 0. In this cell
line, the phoP-based strain exhibited the same degree of
attenuation as in human PBMC, replicating about 18-fold less
than MT103 strain at day 7 of infection. The vaccine strain M.
bovis BCG Pasteur 1173P2 was also used in the THP-1 growth
assays, exhibiting similar impaired replication as SO2 when
compared to virulent MT103 strain (data not shown).
Increased adhesion of SO2 mutant to human
macrophages
As described above, human PBMC and THP-1 macrophages
were infected at MOI 1:1 (greater MOI than that in the replication
assays due to the low percentage of bound bacteria). Cells were
incubated during 4 h at 4uC to avoid phagocytosis, and after
removing extracellular bacteria, cells were lysed to obtain only the
mycobacteria bound to macrophages and analysis was made by
CFU counts.
Percentage of adhesion to cells was measured as the amount of
bound bacteria with respect to inoculated mycobacteria. Results
showed an increase in the SO2 adhesion to human macrophages
in comparison with wild-type strain MT103 (Figure 2). For
PBMC, the percentage of SO2 adhesion to macrophages was
approximately double that of wild-type strain (Figure 2A). For the
THP-1 cell line, SO2 adhesion was up to 4-fold higher when
compared to MT103 (Figure 2B).
Alteration of SO2 trafficking within THP-1 macrophages
Due to the differences observed between SO2 and wild-type
strain, both in adhesion to macrophages and intracellular growth,
we sought to examine whether a significant alteration in the
intracellular trafficking upon SO2 phagocytosis is produced. THP-
1 cells were infected with mycobacteria and after 48 h of infection
mycobacterial colocalization with cellular compartments of
infected macrophages was analyzed by immunofluorescence.
The MT103 strain, which evades the phagolysosome maturation,
was used as negative control and heat-inactivated MT103, which
follows the classical phagocytosis route, was used as positive
control.
Confocal images of mycobacterial colocalization with Lyso-
tracker showed similar colocalization of SO2 and heat-inactivated
MT103 to acidic compartments of infected THP-1 cells in contrast
to the wild-type strain, which hardly colocalized to these
compartments (Figure 3A). For colocalization percentages, we
counted isolated mycobacteria inside macrophages obtaining the
same results as we observed in confocal images, a high
colocalization for heat-inactivated MT103 and SO2 (approxi-
mately 95% and 79%, respectively) against 1% colocalization of
MT103 (Figure 3B).
In order to analyze in more detail the effect on phagolysosome
maturation following mycobacterial infection, we studied coloco-
lization with lysosome-associated membrane protein-1 (LAMP-1)
TB phoP- in Human Macrophages
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glycoprotein characteristic of late-compartments of the phagocytic
route (late endosome-phagosome and phagolysosome, respective-
ly). Figures 4A and 5A show representative images of mycobac-
terial colocalization with LAMP-1 and CD63, respectively. Heat-
killed MT103 and SO2 strain showed similar high levels of
colocalization with LAMP-1 (70% and 80%, respectively), whereas
virulent MT103 exhibited reduced colocalization (25%)
(Figure 4B). However, in the case of CD63, a phagolysosome
marker, both SO2 and MT103 revealed poor colocalization (35%
and 20%, respectively) against the 75% colocalization observed in
the infection with heat-inactivated MT103 (Figure 5B) over the
period of 48 h.
Similar NO production by infected macrophages and NO
mycobacterial resistance
In addition to the phagolysosome formation, the production of
nitric oxide (NO) by the infected macrophage is another
mechanism of defense against Mtb in this cell type [23,24]. In
fact, inducible NO synthase expression and generation of reactive
nitrogen intermediates by alveolar macrophages are increased in
patients infected with Mtb [25].
To determine whether the NO mechanism is responsible for the
impaired intracellular replication of SO2 strain inside human
macrophages, we evaluated NO production by SO2-infected
THP-1 macrophages and SO2-susceptibility to NO. NO produc-
tion by THP-1 cells infected with SO2 or MT103 was measured
indirectly by the presence of nitrites (NO2
2) in the removed
supernatants at different MOI and times of infection, using heat-
inactivated MT103 as negative control. The obtained data showed
similar levels of NO production by SO2 and MT103-infected
macrophages in contrast to heat-inactivated MT103 (Figure S1A).
These results were obtained for all MOI variations and incubation
periods (data not shown), where the nitrite levels increased with
the infection period and MOI in agreement with previous results
described elsewhere [26–29]. We analyzed whether attenuation of
SO2 could be characterized by greater susceptibility to NO when
compared to the wild-type strain. In this context, aliquots of
MT103 and SO2 were incubated at pH 5.5 in presence of
increasing concentrations of NaNO2 (source of exogenous NO)
and at days 1, 4 and 5, aliquots were plated to study the
mycobacterial viability by CFU counts. The assays performed with
the 0–50 mM range of NaNO2, which corresponds to the same
NO concentration levels obtained by the infected macrophages in
Figure 1. Intracellular replication within human macrophages. Data express the fold increase of cfu with respect to day 0 of infection (4 h)
per well, in logarithmic scale. A) Infection of human PBMC. MOI 1:10. B) Infection of THP-1 macrophages. MOI 1:10. Mean values are the result of three
independent experimental data 6 SD, and asterisks indicate statistical significance (P#0.05) using Student’s t-test.
doi:10.1371/journal.pone.0012978.g001
TB phoP- in Human Macrophages
PLoS ONE | www.plosone.org 4 September 2010 | Volume 5 | Issue 9 | e12978the previous assay of NO production, did not affect SO2 or
MT103 viability even with the increase of incubation time (data
not shown). However, when we used a higher range of NaNO2
concentrations (0.1 mM–10 mM) (Figure S1B), we observed an
important decrease in mycobacterial viability for both strains with
increasing NO amounts, resulting more evident at day 5 of
incubation. Nevertheless, this decrease of mycobacterial viability
was shown to be similar for both MT103 and SO2 strains at
analyzed days, suggesting that SO2 was no more susceptible to
exogenous NO than its wild-type strain.
Discussion
The livevaccine candidate SO2 wasconstructed bydisrupting the
phoP gene coding for the transcription factor of the TCS PhoP/R,
essentialforMtbvirulence[12].ThephoPmutantSO2wasunableto
replicate but persisted in murine macrophages and was attenuated in
vivo inmice[12].SO2 showed significant protective effectagainstTB
in guinea pigs and non-human primates [14,15] demonstrating high
potential as live-attenuated vaccine candidate against TB. In the
present study we addressed the intracellular replication of SO2 in
human macrophages with the aim to see if the phoP-based mutant
presents an attenuated phenotype in human macrophages.
For these assays, we selected primary macrophages from human
PBMC and THP-1 cell line, which has alveolar macrophage
characteristics when stimulated and differentiated with PMA [30].
In both types of macrophages SO2 demonstrated an attenuated
phenotype characterized by an impaired intracellular replication
with the same attenuation ratio in contrast to wild-type MT103.
Due to the potential variability with PBMCs from different donors,
we performed the assays with cells from various donors, obtaining
consistent results for the different strains with patent attenuation
for SO2. As to previous results demonstrating the inability of SO2
to replicate in murine macrophages [12], SO2 showed limited
replication in the two types of human macrophages types which
was also observed for BCG in the THP-1 cell line (unpublished
results). Results showed similar intracellular growth pattern
between both strains (data not shown), obtaining comparable
degree of attenuation between BCG and SO2 in human THP-1
derived macrophages. When SO2 was complemented the
replication phenotype was reverted, confirming that the phoP gene
regulates intracellular growth in human macrophages in vitro,
correlating with murine studies [12].
The first step in the mycobacterial infection is adhesion and
mycobacterial recognition by the host cell. Recent studies have
established the Mtb cell envelope as a critical determinant in Mtb–
host interactions and mycobacterial virulence. In this context the
lipid pattern on the mycobacterial envelope of the phoP mutant
from MT103 was previously studied by our group [16], showing
that the mutant lacks the immunomodulatory cell-wall lipids
diacyltrehaloses (DAT) and polyacyltrehaloses (PAT) [16], It has
been reported that deficiency in some forms of DAT and PAT
affects the surface properties of Mtb, resulting in enhanced
interaction with host cells [31]. On the other eventhough hand,
these lipids are only present in the pathogenic mycobacteria, SO2
attenuation may not totally be attributed to the lack of these
virulence-associated lipids, since mutants in DAT and PAT
synthesis do not develop a marked reduction in virulence neither
in vitro nor in vivo in mice [19,31–34].
Moreover, the structure of the major non-peptidic antigen of
mycobacterial cell walls, mannosylated lipoarabinomannan (Man-
LAM), was studied in the phoP mutant and it was found that there
was an increase in the relative abundance of the monoacylated
form of the molecule in SO2, as to wild-type MT103 suggesting
that phoP gene could be implicated in the modulation of the acyl
forms of ManLAM [35]. ManLAM plays an important role in
Mtb interactions with the host through pattern recognition
receptors [36]. Results from studying SO2 adhesion to human
macrophages from PBMC and THP-1 cells showed significantly
higher adhesion phenotype when compared to wild-type MT103.
The phoP-complemented strain, SO2-pSO5, recovered the
adhesion phenotype of the wild-type strain, suggesting that the
phoP gene is required for this feature. The increased abundance of
monoacylated ManLAMs molecules and lack of virulence-
associated immunomodulatory cell wall lipids, such as DAT and
PAT, (involved in mycobacterial interaction with host cells [31]),
could play part in the adherence phenotype displayed by SO2.
Due to this altered lipid expression profile, the change in the SO2
interaction with macrophages, characterized by a higher adhesion
phenotype could be associated with a different mycobacterial
association with the phagocytic receptors, leading to an alteration
in the route for mycobacteria upon phagocytosis [37,38].
Since the altered SO2 interaction with macrophages could lead
to a different mycobacterial intracellular route, as well as SO2
attenuation could be due to inability to inhibit phagosome
maturation characteristic of the wild-type strain, we used
immunofluorescence assays to examine the intracellular trafficking
of SO2 in THP-1 cells following phagocytosis. Significant
differences in the intracellular trafficking between SO2 strain
Figure 2. Mycobacterial adhesion to human macrophages. Data
express the percentage of bound mycobacteria with respect to
mycobacterial inoculum. A) Human PBMC. MOI 1:1. B) THP-1
macrophages. MOI 1:1. Mean values are the result of three independent
experimental data 6 SD, and asterisks indicate statistical significance
(P#0.05) using Student’s t-test.
doi:10.1371/journal.pone.0012978.g002
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non-acidic mycobacterial phagosome, we first analyzed the
presence of SO2 in the acidic compartments by colocalization
with LysoTracker. In contrast to MT103, SO2 (like heat-
inactivated MT103) failed to block the phagosome maturation
indicated by high levels of colocalization to these acidic
compartments. Recently the correlation between PhoP regulation
and ESX-1 secretion system in intracellular mycobacteria has been
described, demonstrating that ESAT-6 secretion by Mtb and
specific T-cell recognition are under the control of PhoP
[20,39,40]. The ESX-1 is required for phagosome maturation
arrest [41], and the fact that SO2 has lost the capacity to export
ESAT-6 in addition to the reduced expression of several other
esx-1 genes make a plausible explanation to why SO2 fails to
induce phagosome maturation arrest.
In order to analyze in more detail the cell trafficking route of
SO2, we used two different lysosome-associated membrane
glycoproteins as organelle markers, LAMP-1 and CD63, previ-
ously described in late endosome-phagosomes and phagolysomes
[38,42]. Similar to the LysoTracker results, we observed high
colocalization of SO2 with LAMP-1, late endosome-phagosome
and phagolysome marker, suggesting that SO2 does not escape
phagosomal maturation, in contrast to the pathogenic wild-type
strain. However, when a later marker of the endocytic route was
Figure 3. Confocal microscopy analysis of LysoTraker-stained infected macrophages. A) Representative images of THP-1 macrophages
infected with live MT103, heat-killed MT103 and SO2 strains. MOI 1:1. After 48 h of infection, cells were stained in red fluorescence with LysoTraker
and mycobacteria in green fluorescence. Bars: 40 mm. Colocalization of both red and green fluorescence indicate that the mycobacteria reside in
acidic compartments. B) Quantification of mycobacterial intracellular trafficking into acidified compartments. Data express the percentage of
mycobacteria inside LysoTraker-compartments with respect to internalized mycobacteria into THP-1 cells. Mean values are the result of three
independent experimental data 6 SD, and asterisks indicate statistical significance (P#0.05) using Student’s t-test.
doi:10.1371/journal.pone.0012978.g003
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showed poor colocalization with this marker, displaying a
persistence phenotype as described previously by our group for
murine macrophages [12]. Persistence has been shown to be
important for the generation of long-lasting protective immunity in
vivo [43], supported by previous studies which demonstrated that
BCG persistence results in prolonged antigen presentation and
generation of memory CD8+ T cells in mice [44]. The impaired
replication and the persistence phenotype of SO2 in human
macrophages could be a beneficial characteristic for a vaccine
candidate, being attenuated but with the potential to effectively
stimulate the host immune system without causing disease. This
was also described for the antigen 85A-deficient mutant of Mtb
(DfbpA), a candidate vaccine with an enhanced immunogenicity
profile presenting an altered intracellular trafficking behavior in
macrophages, as DfbpA containing phagosomes were able to fuse
with late endosomes but failed to acquire rab7 and CD63 markers,
avoiding lysosomal fusion [45].
Apart from the phagolysosome formation, another mechanism of
the innate defense against mycobacteria is the production of NO
and reactive nitrogen intermediates by infected macrophages upon
mycobacterial infection [23,24,25]. In contrast to the murine
models of TB, there is a greater controversy on the role of NO in
killing or limiting the growth of Mtb in humans; nevertheless, there
is a growing body of evidence that NO produced by TB-infected
human macrophages is also antimycobacterial against Mtb, as seen
Figure 4. Confocal microscopy analysis of mycobacterial intracellular localization in human macrophages. A) Representative images of
LAMP-1-stained THP-1 macrophages infected with live MT103, heat-killed MT103 and SO2 strains. MOI 1:1. After 48 h of infection, LAMP-1
compartments were stained in red and mycobacteria in green. Bars: 20 mm. B) Quantification of mycobacterial intracellular trafficking into late
phagosomes and phagolysosomes. Data express the percentage of mycobacteria inside LAMP-1-compartments with respect to internalized
mycobacteria into THP-1 cells. Mean values are the result of three independent experimental data 6 SD, and asterisks indicate statistical significance
(P#0.05) using Student’s t-test.
doi:10.1371/journal.pone.0012978.g004
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that NO production was similar for both attenuated SO2 and wild-
type strains in THP-1 derived human macrophages, contrasting
with previous results demonstrating that certain attenuated strains
as H37Ra induced significantly higher levels of NO than their
virulent counterparts H37Rv in infected PBMC cells [23]. In
addition,the toleranceofmycobacteriatoNOinvitroisstrain-,dose-
and time- dependent the pathogens being inherently more resistant
than non-pathogenic [26–29]. However we demonstrate no
significant differences in NO susceptibility between SO2 and wild-
type MT103, discarding the NO mechanism as responsible for the
SO2 attenuation (which is in agreement with previous reports from
other attenuated Mtb strains [49]).
The results in this work demonstrating the attenuation,
impaired replication, persistence and the different cell trafficking
of SO2 in human macrophages provide a first glimpse of the
behavior of this live-attenuated mutant in the human cellular
model in vitro and are a first step to understanding the intracellular
mode of action of this potential live vaccine candidate against TB.
Supporting Information
Figure S1 NO production by infected macrophages and
mycobacterial susceptibility to exogenic NO. A) NO production
by infected THP-1 macrophages at day 4 (96 hours) with a MOI
of 1:1. B) Mycobacterial susceptibility to exogenic NO. Data
Figure 5. Confocal microscopy analysis of mycobacterial intracellular localization in human macrophages. A) Representative images of
CD63-stained THP-1 macrophages infected with live MT103, heat-killed MT103 and SO2 strains. MOI 1:1. After 48 h of infection, CD63 compartments
were stained in red fluorescence and mycobacteria in green fluorescence. Arrows indicate colocalization. Bars: 20 mm. B) Quantification of
mycobacterial intracellular trafficking into phagolysosomes. Data express the percentage of mycobacteria inside CD63-compartments with respectt o
internalized mycobacteria into THP-1 cells. Mean values are the result of three independent experimental data 6 SD, and asterisks indicate statistical
significance (P#0.05) using Student’s t-test.
doi:10.1371/journal.pone.0012978.g005
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10 mM NaNO2, at pH 5.5, at days1 and 5. Mean values are the
result of three independent experimental data 6 SD, and the
Student’s t-test was used to determine statistical significance (P #
0.05).
Found at: doi:10.1371/journal.pone.0012978.s001 (9.80 MB
TIF)
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